Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

58 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
An open-label study of the pharmacokinetics and pharmacodynamics of dabigatran etexilate 150mg once daily in Caucasian patients with moderate renal impairment undergoing primary unilateral elective total knee or hip replacement surgery.
Eriksson BI, Mikuska Z, Feuring M, Amiral J, Haertter S, Stangier J, Nehmiz G, Weitz JI. Eriksson BI, et al. Among authors: stangier j. Thromb Res. 2016 Aug;144:158-64. doi: 10.1016/j.thromres.2016.06.017. Epub 2016 Jun 16. Thromb Res. 2016. PMID: 27352238 Clinical Trial.
A new oral direct thrombin inhibitor, dabigatran etexilate, compared with enoxaparin for prevention of thromboembolic events following total hip or knee replacement: the BISTRO II randomized trial.
Eriksson BI, Dahl OE, Büller HR, Hettiarachchi R, Rosencher N, Bravo ML, Ahnfelt L, Piovella F, Stangier J, Kälebo P, Reilly P; BISTRO II Study Group. Eriksson BI, et al. Among authors: stangier j. J Thromb Haemost. 2005 Jan;3(1):103-11. doi: 10.1111/j.1538-7836.2004.01100.x. J Thromb Haemost. 2005. PMID: 15634273 Free article. Clinical Trial.
58 results